Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where trifluoromethyl and Boc-protected amine functionalities are required. Its structure allows for selective coupling reactions in peptide-like chain extensions, making it valuable in medicinal chemistry for constructing complex molecules. Commonly employed in research settings for designing drug candidates targeting central nervous system disorders and inflammatory conditions due to the metabolic stability imparted by the trifluoromethyl group.